A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults

PURPOSE/BACKGROUND: Psychostimulant augmentation is considered a potential treatment strategy for individuals with major depressive disorder who do not adequately respond to antidepressant monotherapy. The primary objective of this 12-month open-label extension study was to evaluate the safety and t...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Psychopharmacol
Hoofdauteurs: Richards, Cynthia, Iosifescu, Dan V., Mago, Rajnish, Sarkis, Elias, Geibel, Brooke, Dauphin, Matthew, McIntyre, Roger S., Weisler, Richard, Brawman-Mintzer, Olga, Gu, Joan, Madhoo, Manisha
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Lippincott Williams & Wilkins 2018
Onderwerpen:
Original Contributions
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6039401/
https://ncbi.nlm.nih.gov/pubmed/29912786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000897
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items